Squarepoint’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,825
Closed -$99.8K 3149
2024
Q2
$99.8K Buy
+17,825
New +$99.8K ﹤0.01% 2266
2024
Q1
Sell
-28,960
Closed -$151K 3053
2023
Q4
$151K Buy
28,960
+18,075
+166% +$94.5K ﹤0.01% 2203
2023
Q3
$172K Buy
+10,885
New +$172K ﹤0.01% 2160
2023
Q2
Sell
-33,498
Closed -$950K 2941
2023
Q1
$950K Sell
33,498
-1,322
-4% -$37.5K ﹤0.01% 1191
2022
Q4
$1.02M Buy
34,820
+10,910
+46% +$319K ﹤0.01% 1094
2022
Q3
$632K Buy
23,910
+15,632
+189% +$413K ﹤0.01% 1307
2022
Q2
$368K Sell
8,278
-1,192
-13% -$53K ﹤0.01% 1490
2022
Q1
$469K Buy
9,470
+1,068
+13% +$52.9K ﹤0.01% 1528
2021
Q4
$428K Buy
+8,402
New +$428K ﹤0.01% 1686
2021
Q3
Sell
-5,197
Closed -$222K 2861
2021
Q2
$222K Buy
+5,197
New +$222K ﹤0.01% 2154
2021
Q1
Sell
-8,381
Closed -$390K 3148
2020
Q4
$390K Sell
8,381
-4,953
-37% -$230K ﹤0.01% 1681
2020
Q3
$566K Buy
13,334
+8,077
+154% +$343K 0.01% 1268
2020
Q2
$252K Sell
5,257
-11,338
-68% -$543K ﹤0.01% 1656
2020
Q1
$763K Sell
16,595
-15,964
-49% -$734K 0.02% 839
2019
Q4
$1.96M Buy
32,559
+24,721
+315% +$1.49M 0.01% 898
2019
Q3
$443K Sell
7,838
-18,771
-71% -$1.06M ﹤0.01% 1620
2019
Q2
$1.48M Sell
26,609
-7,591
-22% -$423K 0.01% 1000
2019
Q1
$1.73M Sell
34,200
-3,988
-10% -$201K 0.02% 839
2018
Q4
$1.54M Buy
+38,188
New +$1.54M 0.02% 751
2018
Q2
Sell
-4,747
Closed -$250K 2109
2018
Q1
$250K Sell
4,747
-47,613
-91% -$2.51M ﹤0.01% 1395
2017
Q4
$2.8M Buy
+52,360
New +$2.8M 0.05% 427
2017
Q3
Sell
-46,425
Closed -$3.66M 1928
2017
Q2
$3.66M Buy
46,425
+19,139
+70% +$1.51M 0.07% 330
2017
Q1
$2.26M Buy
+27,286
New +$2.26M 0.06% 351
2016
Q4
Sell
-8,971
Closed -$628K 1965
2016
Q3
$628K Sell
8,971
-2,729
-23% -$191K 0.04% 489
2016
Q2
$454K Buy
+11,700
New +$454K 0.03% 588